help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 5, 2006
Endocrinology, doi:10.1210/en.2005-1300
A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/4/1735    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christoffolete, M. A.
Right arrow Articles by Bianco, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christoffolete, M. A.
Right arrow Articles by Bianco, A. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
*LIOTHYRONINE

Submitted on October 12, 2005
Accepted on December 22, 2005

Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary TSH feedback mechanism

Marcelo A. Christoffolete, Rogério Ribeiro, Praful Singru, Csaba Fekete, Wagner S. da Silva, David F. Gordon, Stephen A. Huang, Alessandra Crescenzi, John W. Harney, E. Chester Ridgway, P. Reed Larsen, Ronald M. Lechan, and Antonio C. Bianco*

Thyroid Section, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston MA 02115; Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, New England Medical Center, 750 Washington St, Boston, MA 02111; Department of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; Department of Medicine/Endocrinology, University of Colorado Health Sciences Center at Fitzsimons, Aurora, CO 80045; Division of Endocrinology, Children's Hospital Boston, Boston, MA 02115

* To whom correspondence should be addressed. E-mail: abianco{at}partners.org.

Thyroxine (T4), the main product of thyroid secretion, is a critical signal in plasma that mediates the TSH (TSH) negative feedback mechanism. As a prohormone, T4 must be converted to T3 to acquire biological activity; thus, type 2 iodothyronine deiodinase (D2) is expected to play a critical role in this feedback mechanism. However, the mechanistic details of this pathway are still missing because, counter-intuitively, D2 activity is rapidly lost in the presence of T4 by a ubiquitin-proteasomal mechanism. In the present study, we demonstrate that D2 and TSH are co-expressed in rat pituitary thyrotrophs and that hypothyroidism increases D2 expression in these cells. Studies using two murine-derived thyrotroph cells, TtT-97 and T{alpha}T1, demonstrate high expression of D2 in thyrotrophs and confirm its sensitivity to negative regulation by T4-induced proteasomal degradation of this enzyme. Despite this, expression of the Dio2 gene in T{alpha}T1 cells is higher than their T4-induced D2 ubiquitinating capacity. As a result, D2 activity and net T3 production in these cells are sustained even at free T4 concentrations that are severalfold above the physiological range. In this system, free T4 concentrations and net D2-mediated T3 production correlated negatively with TSH{beta} gene expression. These results resolve the apparent paradox between the homeostatic regulation of D2 and its role in mediating the critical mechanism by which T4 triggers the TSH negative feedback.


Key words: thyroid • deiodinase • TSH




This article has been cited by other articles:


Home page
EndocrinologyHome page
B. A. Adams, S. L. Gray, E. R. Isaac, A. C. Bianco, A. J. Vidal-Puig, and N. M. Sherwood
Feeding and Metabolism in Mice Lacking Pituitary Adenylate Cyclase-Activating Polypeptide
Endocrinology, April 1, 2008; 149(4): 1571 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al.
Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain
Endocrinology, October 1, 2007; 148(10): 4865 - 4874.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. S Wagner, S. M Wajner, J. M Dora, and A. L. Maia
Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice
J. Endocrinol., June 1, 2007; 193(3): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. S. da-Silva, J. W. Harney, B. W. Kim, J. Li, S. D.C. Bianco, A. Crescenzi, M. A. Christoffolete, S. A. Huang, and A. C. Bianco
The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation
Diabetes, March 1, 2007; 56(3): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Christoffolete, R. Arrojo e Drigo, F. Gazoni, S. M. Tente, V. Goncalves, B. S. Amorim, P. R. Larsen, A. C. Bianco, and A. M. Zavacki
Mice with Impaired Extrathyroidal Thyroxine to 3,5,3'-Triiodothyronine Conversion Maintain Normal Serum 3,5,3'-Triiodothyronine Concentrations
Endocrinology, March 1, 2007; 148(3): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Stojadinovic, B. Lee, C. Vouthounis, S. Vukelic, I. Pastar, M. Blumenberg, H. Brem, and M. Tomic-Canic
Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes: INHIBITION OF APOPTOSIS, INTERFERON-{gamma} PATHWAY, AND WOUND HEALING ALONG WITH PROMOTION OF TERMINAL DIFFERENTIATION
J. Biol. Chem., February 9, 2007; 282(6): 4021 - 4034.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Ortega, N. Pannacciulli, C. Bogardus, and J. Krakoff
Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 440 - 445.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Visser
The elemental importance of sufficient iodine intake: a trace is not enough.
Endocrinology, May 1, 2006; 147(5): 2095 - 2097.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society